Literature DB >> 11127577

Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles.

H Cohen1, R J Levy, J Gao, I Fishbein, V Kousaev, S Sosnowski, S Slomkowski, G Golomb.   

Abstract

Sustained release polymeric gene delivery systems offer increased resistance to nuclease degradation, increased amounts of plasmid DNA (pDNA) uptake, and the possibility of control in dosing and sustained duration of pDNA administration. Furthermore, such a system lacks the inherent problems associated with viral vectors. Biodegradable and biocompatible poly(DL-lactide-co-glycolide) polymer was used to enacapsulate pDNA (alkaline phosphatase, AP, a reporter gene) in submicron size particles. Gene expression mediated by the nanoparticles (NP) was evaluated in vitro and in vivo in comparison to cationic-liposome delivery. Nano size range (600 nm) pDNA-loaded in poly(DL-lactide-co-glycolide) polymer particles with high encapsulation efficiency (70%) were formulated, exhibiting sustained release of pDNA of over a month. The entrapped plasmid maintained its structural and functional integrity. In vitro transfection by pDNA-NP resulted in significantly higher expression levels in comparison to naked pDNA. Furthermore, AP levels increased when the transfection time was extended, indicating sustained activity of pDNA. However, gene expression was significantly lower in comparison with standard liposomal transfection. Seven days after i.m. injections in rats, naked pDNA and pDNA-NP were found to be significantly more potent (1-2 orders of magnitude) than liposomal pDNA. Plasmid DNA-NP treatment exhibited increased AP expression after 7 and 28 days indicating sustained activity of the NP.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11127577     DOI: 10.1038/sj.gt.3301318

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  36 in total

1.  Gene delivery in tissue engineering: a photopolymer platform to coencapsulate cells and plasmid DNA.

Authors:  Deborah J Quick; Kristi S Anseth
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 2.  Emerging therapeutic approaches in the management of retinal angiogenesis and edema.

Authors:  An Truong; Tien Y Wong; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2010-12-18       Impact factor: 4.599

3.  Intramuscular delivery of DNA releasing microspheres: microsphere properties and transgene expression.

Authors:  Jae-Hyung Jang; Lonnie D Shea
Journal:  J Control Release       Date:  2006-03-10       Impact factor: 9.776

Review 4.  Biodegradable nanoparticles for cytosolic delivery of therapeutics.

Authors:  Jaspreet K Vasir; Vinod Labhasetwar
Journal:  Adv Drug Deliv Rev       Date:  2007-06-26       Impact factor: 15.470

5.  Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres.

Authors:  Neelesh K Varde; Daniel W Pack
Journal:  J Control Release       Date:  2007-09-21       Impact factor: 9.776

Review 6.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

Review 7.  Targeted polymeric nanoparticles for cancer gene therapy.

Authors:  Jayoung Kim; David R Wilson; Camila G Zamboni; Jordan J Green
Journal:  J Drug Target       Date:  2015-06-10       Impact factor: 5.121

8.  Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Authors:  Toshihiro Kushibiki; Kunio Matsumoto; Toshikazu Nakamura; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200

9.  Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.

Authors:  Kyoungmin Park; Ying Chen; Yang Hu; Aaron S Mayo; Uday B Kompella; Richard Longeras; Jian-xing Ma
Journal:  Diabetes       Date:  2009-06-02       Impact factor: 9.461

Review 10.  Nanoparticulate systems for polynucleotide delivery.

Authors:  Ashwin Basarkar; Jagdish Singh
Journal:  Int J Nanomedicine       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.